In-vitro diagnostic (IVD) solutions player Zhejiang Pushikang Biotechnology Co., Ltd. has pocketed ‘millions of dollars’ in a Series B round of financing led by YuanBio Venture Capital (also known as bioVenture), according to an announcement on Wednesday.
Continue reading this premium story with a subscription to DealStreetAsia.Subscribe
Already a Subscriber? Log in
Contact us for corporate subscriptions at firstname.lastname@example.org